Wellness Briefing: Hims & Hers plots rapid expansion into peptide therapies like BPC-157, plus news
Culture Index
Score Breakdown
Relevance
11/25
Freshness
24/25
Authority
18/20
Brand Signal
9/15
Depth
4/15
5-Axis Cultural Radar
For the Wellness Briefing, Glossy is unpacking Hims & Hers Q2 earnings meeting where CEO Andrew Dudum explained the telehealth’s plan to rapidly expand into six experimental peptide therapies including BPC-157, TB-500, MOTS-c, and more. Additionally, Google unveils a new health partnership, the men’s health and wellness market surges in growth, and a breakdown on the new lawsuit against Selena Gom
